(The following statement was released by the rating agency)
SHANGHAI, November 23 (Fitch) Fitch Ratings expects China's
pharmaceutical sales
through hospitals and retail pharmacies to maintain a healthy
growth over the
medium term. This momentum is underpinned by rising medical
demand from an
ageing population; continuing urbanisation; rising disposable
income; broadening
medical insurance coverage; and improving public access to
medical treatment and
facilities.
However, our growth outloo
Read more
No comments:
Post a Comment